In studies performed in the general population, those receiving insulin-treatment have a remarkably higher incidence of cancer [52]; however, the large majority of those not receiving insulin are not affected by diabetes; considering that diabetes per se is a risk factor for malignancies, the difference in incidence of cancer could be due to diabetes rather than to insulin therapy. The gene discussed is INS; the disease is diabetes mellitus.